Prot# CAQW051A2202: A Single-Dose, Placebo-Controlled, Stratified, Randomized, Double-Blind, Crossover Study to Determine the Pharmacodynamic Effects of AQW051 Followed by a 4-Week Multiple-Dose, Placebo-Controlled, Stratified, Randomized, Double-Blind,

Project: Research project

Project Details

StatusFinished
Effective start/end date3/3/09 → 12/31/11

Funding

  • Novartis Pharmaceuticals Corporation (CAQW051A2202)